During the past decade, USF - Tampa NICHD CRS conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "USF - Tampa NICHD CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 14 trials, followed by "University of South Florida" with 4 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "KU Leuven" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "USF - Tampa NICHD CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 12 trials as a collaborator, "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 1 trials as a collaborator and "PENTA Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "USF - Tampa NICHD CRS" are "HIV Infections" (13 trials), "Crohn's Disease" (2 trials), "H1N1 Influenza Virus" (2 trials), "Adnexal Masses" (1 trials) and "Breastfeeding" (1 trials). Many other conditions were trialed in "USF - Tampa NICHD CRS" in a lesser frequency.

Most popular intervention types in "USF - Tampa NICHD CRS" are "Drug" (10 trials), "Biological" (7 trials), "Device" (3 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AMS Ambicor" (1 trials), "Abacavir sulfate" (1 trials), "Abacavir sulfate, lamivudine, and zidovudine" (1 trials) and "Aldesleukin" (1 trials). Other intervention names were less common.

The vast majority of trials in "USF - Tampa NICHD CRS" are 16 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "USF - Tampa NICHD CRS". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in USF - Tampa NICHD CRS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in USF - Tampa NICHD CRS, 6 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".